tiprankstipranks
Trending News
More News >
Pharming Group (NL:PHARM)
:PHARM
Netherlands Market

Pharming Group (PHARM) Income Statement

Compare
27 Followers

Pharming Group Income Statement

Last quarter (Q4 2025), Pharming Group's total revenue was $91.50M, a decrease of -1.26% from the same quarter last year. In Q4, Pharming Group's net income was $4.55M. See Pharming Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 333.28M$ 286.89M$ 245.32M$ 205.62M$ 189.85M
Gross Profit
$ 292.97M$ 231.82M$ 220.10M$ 188.06M$ 169.67M
Operating Expenses
$ 275.85M$ 235.21M$ 225.49M$ 169.83M$ 156.72M
Depreciation and Amortization
$ 9.94M$ 10.21M$ 15.93M$ 13.19M$ 19.61M
EBITDA
$ 27.05M$ 13.18M$ 9.88M$ 33.53M$ 48.78M
Operating Income
$ 17.11M$ -3.39M$ -4.88M$ 18.23M$ 27.84M
Other Income/Expenses
$ -5.73M$ -4.46M$ -7.13M$ -3.25M$ -4.76M
Pretax Income
$ 11.38M$ -7.85M$ -12.01M$ 14.99M$ 22.03M
Net Income
$ 2.53M$ -10.64M$ -10.55M$ 13.67M$ 16.00M
Per Share Metrics
Basic EPS
$ <0.01$ -0.02$ -0.01$ 0.02$ 0.02
Diluted EPS
$ <0.01$ -0.02$ -0.01$ 0.02$ 0.02
Weighted Average Shares Outstanding
721.77M 689.19M 821.28M 883.93M 876.44M
Weighted Average Shares Outstanding (Diluted)
721.77M 689.19M 843.25M 883.93M 876.44M
Currency in USD

Pharming Group Earnings and Revenue History